Logo image of BH

BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

NYSE:BH - New York Stock Exchange, Inc. - US08986R3093 - Common Stock - Currency: USD

246.42  +12.09 (+5.16%)

After market: 246.42 0 (0%)

Fundamental Rating

2

BH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of BH is average, but there are quite some concerns on its profitability. BH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BH has reported negative net income.
In the past year BH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BH reported negative net income in multiple years.
In the past 5 years BH always reported a positive cash flow from operatings.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.43%, BH is doing worse than 64.44% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.66%, BH is in line with its industry, outperforming 52.59% of the companies in the same industry.
BH's Return On Invested Capital of 2.63% is on the low side compared to the rest of the industry. BH is outperformed by 69.63% of its industry peers.
BH had an Average Return On Invested Capital over the past 3 years of 4.28%. This is significantly below the industry average of 14.12%.
Industry RankSector Rank
ROA -0.43%
ROE -0.66%
ROIC 2.63%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

BH has a Operating Margin (6.38%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BH has grown nicely.
Looking at the Gross Margin, with a value of 38.28%, BH is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of BH has grown nicely.
Industry RankSector Rank
OM 6.38%
PM (TTM) N/A
GM 38.28%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BH is destroying value.
BH has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BH has been reduced compared to 5 years ago.
The debt/assets ratio for BH is higher compared to a year ago.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.70 indicates that BH is not a great score, but indicates only limited risk for bankruptcy at the moment.
BH's Altman-Z score of 2.70 is fine compared to the rest of the industry. BH outperforms 76.30% of its industry peers.
BH has a debt to FCF ratio of 5.98. This is a neutral value as BH would need 5.98 years to pay back of all of its debts.
BH has a better Debt to FCF ratio (5.98) than 73.33% of its industry peers.
BH has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BH (0.19) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 5.98
Altman-Z 2.7
ROIC/WACC0.29
WACC8.97%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BH has a Current Ratio of 1.16. This is a normal value and indicates that BH is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.16, BH is doing good in the industry, outperforming 62.96% of the companies in the same industry.
BH has a Quick Ratio of 1.13. This is a normal value and indicates that BH is financially healthy and should not expect problems in meeting its short term obligations.
BH has a better Quick ratio (1.13) than 64.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.13
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

0

3. Growth

3.1 Past

BH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -144.38%.
BH shows a decrease in Revenue. In the last year, the revenue decreased by -0.87%.
The Revenue for BH have been decreasing by -11.55% on average. This is quite bad
EPS 1Y (TTM)-144.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.17%
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%0.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

BH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

88.89% of the companies in the same industry are more expensive than BH, based on the Enterprise Value to EBITDA ratio.
BH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.47
EV/EBITDA 6.42
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIGLARI HOLDINGS INC-B

NYSE:BH (5/22/2025, 8:04:00 PM)

After market: 246.42 0 (0%)

246.42

+12.09 (+5.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-09 2025-05-09/amc
Earnings (Next)08-07 2025-08-07
Inst Owners88.33%
Inst Owner Change1.42%
Ins Owners0.41%
Ins Owner Change0%
Market Cap561.84M
Analysts43.33
Price TargetN/A
Short Float %13.45%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF 29.47
P/OCF 11.31
P/B 0.98
P/tB 1.13
EV/EBITDA 6.42
EPS(TTM)-7.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)8.36
FCFY3.39%
OCF(TTM)21.78
OCFY8.84%
SpS158.82
BVpS251.3
TBVpS218.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -0.66%
ROCE 3.21%
ROIC 2.63%
ROICexc 3.19%
ROICexgc 3.63%
OM 6.38%
PM (TTM) N/A
GM 38.28%
FCFM 5.27%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexcg growth 3Y-14.08%
ROICexcg growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 5.98
Debt/EBITDA 1.72
Cap/Depr 76.79%
Cap/Sales 8.45%
Interest Coverage 250
Cash Conversion 78.89%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.13
Altman-Z 2.7
F-Score2
WACC8.97%
ROIC/WACC0.29
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-144.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%0.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.42%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.56%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y-31.97%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%